Purpose: To compare cerebrovascular reactivity (CVR) and CVR lagtimes in flow territories perfused by vessels with vs. without proximal arterial wall disease and/or stenosis, separately in patients with atherosclerotic and nonatherosclerotic (moyamoya) intracranial stenosis. Materials and Methods: Atherosclerotic and moyamoya patients with >50% intracranial stenosis and <70% cervical stenosis underwent angiography, vessel wall imaging (VWI), and CVR-weighted imaging (n 5 36; vessel segments evaluated 5 396). Angiography and VWI were evaluated for stenosis locations and vessel wall lesions. Maximum CVR and CVR lagtime were contrasted between vascular territories with and without proximal intracranial vessel wall lesions and stenosis, and a Wilcoxon rank-sum was test used to determine differences (criteria: corrected two-sided P < 0.05). Results: CVR lagtime was prolonged in territories with vs. without a proximal vessel wall lesion or stenosis for both patient groups: moyamoya (CVR lagtime 5 45.5 sec 6 14.2 sec vs. 35.7 sec 6 9.7 sec, P < 0.001) and atherosclerosis (CVR lagtime 5 38.2 sec 6 9.1 sec vs. 35.0 sec 6 7.2 sec, P 5 0.001). For reactivity, a significant decrease in maximum CVR in the moyamoya group only (maximum CVR 5 9.8 6 2.2 vs. 12.0 6 2.4, P < 0.001) was observed. Conclusion: Arterial vessel wall lesions detected on noninvasive, noncontrast intracranial VWI in patients with intracranial stenosis correlate on average with tissue-level impairment on CVR-weighted imaging.
These patients have variable prognoses, which is hypothesized to depend sensitively on the location and extent of steno-occlusion, hemodynamic compensation mechanisms such as the development of collateral vessels, and associated comorbidities. 6 Biomarkers that may stratify new or recurrent stroke risk in patients with moyamoya have not been conclusively established. Evaluation of patients with these intracranial vasculopathies commonly depends on cerebral angiography for stenosis grading and collateral classification and structural magnetic resonance imaging (MRI) for infarct presence. The extent of intracranial vascular stenosis and the presence of collaterals have traditionally been used as surrogates for disease severity and stroke risk. However, angiography provides no direct information on plaque vulnerability in atherosclerotic patients or how arterial stenosis translates to parenchymal impairment at the tissue level in either class of intracranial stenosis. High spatial resolution intracranial vessel wall imaging (VWI) has recently become available and provides a critical step toward understanding intracranial arterial wall pathology by providing morphologic evaluation of the vessel wall (eg, wall thickness and signal characteristics). However, the correlation between intracranial vessel wall characteristics and clinical presentation is only beginning to be understood. [8] [9] [10] [11] [12] Specifically, fundamental gaps exist in our knowledge regarding how intracranial vessel wall pathology correlates with parenchymal impairment; however, this information may be fundamental to understanding the utility of vessel wall imaging for portending recurrent stroke risk. This work aims to improve our understanding of how vessel wall abnormalities manifest in terms of tissue-level cerebrovascular reactivity (CVR) maximum and lagtime. Specifically, it is unclear whether impaired CVR measures in regions perfused by vessels with intracranial stenosis or vessel wall disease represent lower reactivity, delayed reactivity time, or both, and whether these relationships are unique in atherosclerotic vs. nonatherosclerotic intracranial disease. CVR-weighting can be measured using blood oxygenation level-dependent (BOLD) [13] [14] [15] or cerebral blood flow (CBF)-weighted arterial spin labeling (ASL) [16] [17] [18] MRI and a mild hypercapnic challenge. Here, hypercapnic BOLD MRI is applied together with a novel time regression technique 19 that separately quantifies CVR lagtime (ie, time for smooth muscle lining arterioles to maximally relax in response to vasoactive stimuli) and maximum CVR (ie, amount by which arterioles are able to increase CBF and volume in response to vasoactive stimuli). In this study, BOLD MRI was used, rather than ASL MRI, as BOLD MRI is more robust over a large range of blood arrival and vascular reactivity times, which are expected in patients with cerebrovascular disease.
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The purpose of this work is to compare CVR lagtime and maximum in flow territories perfused by vessels with vessel wall disease and/or stenosis to territories perfused by vessels without measurable vessel wall disease or stenosis, separately in the two patient groups. The overall hypotheses are that 1) vessel wall pathology colocalizes with arterial stenosis in the majority of patients in both groups, and 2) lower maximum CVR and prolonged CVR lagtimes are present in flow territories perfused by vessels with vessel wall pathology.
Materials and Methods

Patient Anonymity, Informed consent, and Ethics
All study components were reviewed and approved by the Institutional Review Board. Procedures were followed in accordance with the ethical standards of the Human Research Protection Program and the Helsinki Declaration of 1975 (and as revised in 1983). All components of this study were in compliance with the Health Insurance Portability and Accountability Act (HIPAA). All patients provided informed, written consent.
Inclusion criteria were stroke or transient ischemic attack (TIA) within the past year, intracranial stenosis >50%, extracranial stenosis <70%, and VWI and CVR-weighted imaging performed within the same session between July 2014 and August 2015. A value of <70% extracranial carotid stenosis was chosen, as that is the accepted value for flow-limiting stenosis in the cervical carotid arteries. 22 The value for flow-limiting intracranial stenosis is less clear and thus a value of 50% was chosen, including both moderate and severe stenosis.
Structural Imaging and Angiography
Imaging sessions were performed on a 3T whole-body scanner (Philips Medical Systems, Best, The Netherlands) using body coil transmission and sensitivity encoding (SENSE) array reception. FLAIR (fluid-attenuated inversion recovery) and T 1 -weighted MRI were performed during the same session as VWI and CVR imaging. Acquisitions were performed in the axial plane with repetition time / echo time (TR/TE) 5 11,000/120 msec and 9.0/4.6 msec, for FLAIR and T 1 -weighted, respectively. Patients underwent angiographic imaging with digital subtraction angiography (DSA) (n 5 14), CT angiography (CTA) (n 5 3), or time-of-flight MR angiography (TOF-MRA) (n 5 19) of the intracranial vasculature as part of the same session or within 30 days of MRI. TOF-MRA was acquired in the axial plane using a 3D T 1 -weighted gradient echo (GRE) sequence with TR/TE 5 13. 
CVR-Weighted MRI
Patients underwent BOLD imaging using hypercapnic stimulation.
The stimulus paradigm consisted of 3 minutes hypercapnic hyperoxia (5% CO 2 / 95% O 2 ) administration alternating with 3 minutes medical-grade room air repeated twice. Hypercapnic hyperoxia was used rather than hypercapnic normoxia as hypercapnic hyperoxia (eg, carbogen-5) is a clinical gas mixture available in hospital settings and is therefore a generalizable stimulus to both specialized and nonspecialized centers. Differences in BOLD reactivity between hypercapnic hyperoxia and hypercapnic normoxia stimuli have been investigated in detail in our previous studies 14, 23 and these stimuli provide results that are correlated in both healthy volunteers and patients with cerebrovascular disease. BOLD imaging was performed using single-shot gradient echo-planar acquisition, TR/TE 5 2000/35 msec, spatial resolution 5 3.0 3 3.0 3 3.5 mm 3 , slices 5 31. Acquisition parameters were similar as reported and assessed for reproducibility previously. 14 
Statistical Procedures
CVR lagtime and maximum CVR ( Fig. 1 ) were analyzed using MatLab (MathWorks, Natick, MA) and FMRIB Software Library (FSL) routines. CVR-weighted data were registered to a 4 mm isotropic brain atlas (Montreal Neurological Institute, MNI). Similar as has been reported, 19 the statistical regressor, which consisted of a boxcar convolved with a single-Gaussian was progressed in time, beginning at the start of the hypercapnic stimulus. The maximum z-statistic (eg, maximum CVR) and time lag to reach the maximum CVR (CVR lagtime), which reflects the total time for blood gas to reach the brain parenchyma from compressed cylinders plus the time for the maximum point of vasodilation, were calculated. For each volunteer the mean and standard deviation of the CVR lagtime and maximum CVR were calculated within the six primary intracranial vascular territories including the right and left ACA, MCA, and PCA territories, and within 20 subterritories ( Fig. 1) including the ASPECTs territories 24 (M1-M6) and the corresponding ganglionic (A1, P1) and supraganglionic (A2, P2) segments of the ACA and PCA territories. Across 36 patient volunteers, 396 vessel segments were analyzed on VWI and angiography, in addition to 1) 720 separate parenchymal regions for the subterritories grouping approach and 2) 216 separate parenchymal regions for the flow territory grouping approach. To test the study hypotheses, first we calculated mean values for CVR lagtime and maximum CVR in each of the vascular territories only in regions without a proximal vessel wall lesion or hemodynamically significant stenosis (> 50% luminal narrowing). The term no proximal vessel disease will be used synonymously with no detectable proximal vessel wall lesion or stenosis. The ACA territories were considered to have a proximal vessel wall lesion if there was an ipsilateral ACA or ICA lesion, MCA territories if there was an ipsilateral MCA or intracranial ICA lesion, PCA territories if there was a lesion of the ipsilateral PCA, vertebral artery or basilar artery.
Next, for each of the atherosclerosis and moyamoya groups, the CVR lagtime and maximum CVR were separately compared between territories with no discernible proximal vessel wall lesion or stenosis and territories 1) with a proximal vessel wall lesion or stenosis; 2) with a proximal vessel wall lesion; and 3) with a proximal stenosis. Note that the territories with a proximal vessel wall lesion and proximal stenosis are not exclusive of one another. Analysis of territories with a proximal vessel wall lesion only (vessel wall lesion without a corresponding stenosis on angiography) was also included for the atherosclerosis patients. Analysis of this category was not included for the moyamoya patients due to the very small number of territories meeting these criteria in this population, as expected. Similarly, evaluation of territories with a proximal stenosis only (stenosis without discernible vessel wall lesion) was not included for either patient group, as this subcategory was very rarely observed and is generally not expected physiologically. The mean, standard deviation, and 95% confidence intervals were calculated for each of the above groups. A nonparametric Wilcoxon rank-sum test was used to determine differences of study variables between vessel types, and corresponding (maximum six comparisons) Bonferroni-corrected twosided P-values were calculated with criteria for significance being corrected P < 0.05. The above comparisons were also performed considering each of the subterritories individually.
Several additional analyses were performed as well. To evaluate for the effect of prior infarcts on the CVR analysis, the CVR lagtime and maximum CVR were compared between all territories with a proximal vessel wall lesion or stenosis and the same group excluding the territories of encephalomalacia from prior infarct, as determined on FLAIR imaging. This analysis was performed separately for the atherosclerosis and moyamoya patient groups. To evaluate the effect of prior EDAS (encephaloduroarteriosynangiosis), the CVR lagtime and maximum CVR were compared between territories with vs. without a proximal vessel wall lesion or stenosis for all moyamoya patients, moyamoya patients with prior EDAS, and moyamoya patients without prior EDAS.
Results
Patients Thirty-six patients (mean age 5 51 years; range 5 25-83 years) comprising 12 males (mean age 5 53 years, range 5 25-83 years) and 24 females (mean age 5 50 years, range 5 28-74 years) were included and stratified by disease: atherosclerosis (n 5 16; mean age 5 64 years, range 5 49-83 years) or nonatherosclerosis (moyamoya; n 5 20; mean age 5 40 years, range 5 25-60 years). Moyamoya patients carried a diagnosis of idiopathic moyamoya (n 5 18), moyamoya secondary to childhood radiation (n 5 1), and moyamoya secondary to sickle cell disease (n 5 1). In the moyamoya group, 12/20 (60%) patients had undergone prior (duration 5 17.2 months; range 5 6-45 months) EDAS. Per inclusion criteria all patients had prior stroke or TIA. Approximately 80% (13/16) of the atherosclerosis patients had sequela of prior infarcts documented on FLAIR imaging, seven patients with lacunar infarcts and six patients with cortical infarcts involving approximately one of the subterritories. In the moyamoya group, 14/20 (70%) patients had evidence of prior infarcts of FLAIR imaging including three patients with lacunar infarcts and 11 patients with cortical infarcts involving on average two of the subterritories. Table 1 shows the number of vessel wall lesions and stenoses detected in each patient group. In both the atherosclerosis 
Vessel Wall Lesions vs. Luminal Stenosis
CVR-Weighted MRI
Representative patient examples are shown in Fig. 2 . CVR lagtime and maximum CVR in territories without a discernible proximal vessel wall lesion or hemodynamically significant stenosis are summarized in Table 2 . The number of vascular territories without a proximal vessel wall lesion or significant stenosis was 19, 12, and 55 for the ACA, MCA, and PCA territories, respectively. Figure 3 and Supplemental Table 1 summarize the mean CVR lagtime and maximum CVR for all vascular territories comparing those territories without a discernible proximal vessel wall lesion or stenosis to those 1) with a proximal vessel wall lesion or stenosis; 2) with a proximal vessel wall lesion; 3) with a proximal vessel wall lesion only; and 4) with a proximal stenosis for the atherosclerosis patients. CVR lagtime was significantly lengthened in vascular territories with vs. without a proximal vessel wall lesion or stenosis in the atherosclerosis group (CVR lagtime 5 38.2 sec 6 9.1 sec vs. 35.0 sec 6 7.2 sec, P 5 0.001) and similar results were found when comparing regions with a proximal vessel wall lesion or proximal stenosis to those with no proximal vessel disease. There was no significant difference in the maximum CVR between territories with vs. without proximal vessel disease in the atherosclerosis group. Figure 4 and Supplemental Table 1 summarize the mean CVR lagtime and maximum CVR for all territories comparing those territories without a discernible proximal vessel wall lesion or stenosis to those 1) with a proximal vessel wall lesion or stenosis; 2) with a proximal vessel wall lesion; and 3) with a proximal stenosis for the moyamoya patients. The CVR lagtime was prolonged in territories with proximal vessel lesion or stenosis vs. in those without (CVR lagtime 5 45.5 sec 6 14.2 sec vs. 35.7 sec 6 9.7 sec, P < 0.001). Similar analysis for maximum CVR showed a significant decrease in the maximum CVR in territories with a proximal vessel wall lesion or stenosis compared to regions without (maximum CVR 5 9.8 6 2.2 vs. 12.0 6 2.4, P < 0.001). Figure 5 summarizes the mean CVR lagtime and maximum CVR for territories with vs. without a proximal vessel wall lesion or stenosis for all moyamoya patients, moyamoya patients with prior EDAS, and moyamoya patients without prior EDAS. In all groups, there was a significant difference between territories with vs. without proximal vessel disease. Additionally, there were differences in the CVR lagtime and maximum CVR between patients with and without prior EDAS. Table 1 shows the mean CVR lagtime and maximum CVR compared between all territories with a proximal vessel wall lesion or stenosis and all territories with a proximal vessel wall lesion or stenosis excluding territories with evidence of prior infarct. In total, only 7/216 (3%) of the subterritories with a proximal vessel wall lesion in the atherosclerosis patients and 20/286 (7%) of such territories in the moyamoya patients demonstrated changes of prior infarct and were excluded. No significant difference was found in the CVR lagtime or maximum CVR in either patient group after removing the territories with sequela of prior infarcts. This finding is not surprising, given the relatively small volume of infarct relative to the total volume considered in analysis.
CVR-Weighted MRI: Atherosclerosis Patients
CVR-Weighted MRI: Moyamoya Patients
Discussion
We applied intracranial VWI without intravenous contrast in patients with intracranial stenosis. Findings suggest that the presence of vessel wall lesions correlates with functional changes in CVR. The use of a novel time regression technique 19 has allowed separate calculation of the maximum CVR and CVR lagtime. It was observed that in nonatherosclerotic intracranial disease (eg, moyamoya), maximum CVR is lower and CVR lagtime longer in flow territories perfused by arteries with vessel wall lesions. In atherosclerotic disease, CVR lagtime is most consistently lengthened in territories perfused by arteries with vessel wall lesions. When the locations of vessel wall lesions were compared with the locations of hemodynamically significant (>50%) stenosis, the two corresponded in the majority of the moyamoya patients. However, the correlation of vessel wall lesions with stenosis was variable in the atherosclerosis group, with less than half of the detected vessel wall lesions demonstrating greater than 50% stenosis on angiography. Van der Kolk et al 25 similarly showed a relatively small overlap of vessel wall lesions and stenosis in a group of patients composed primarily of atherosclerotic intracranial stenosis with 14/52 detected vessel wall lesions having corresponding stenosis on MRA. One factor contributing to the underestimation of intracranial plaque burden on angiography may be the presence of arterial remodeling with a compensatory dilatation of the arterial lumen at the plaque location. Even with an extensive plaque, remodeling of the arterial vasculature, with a compensatory enlargement of the vessel size at the location of the plaque, will result in a normal appearance of the lumen on angiography. 26, 27 The clinical significance of intracranial vessel wall disease that does not result in hemodynamically significant stenosis remains a question but may be important as a long-term vascular risk factor, as shown in other vessels. 28 This works shows a strong trend toward prolongation of CVR lagtime in territories with a proximal vessel wall lesion only compared to territories with no proximal vessel disease, which suggests functional significance of vessel lesions in the absence of stenosis. As such, VWI may be used as a complement to angiography to understand the spectrum of vascular disease, and future work is required to investigate the clinical importance of this more thoroughly. Studies of coronary and carotid arteries have similarly shown clinical significance of plaque that results in <50% stenosis on angiography. FIGURE 3: Mean 6 standard deviation of the CVR lagtime (A) and maximum CVR (B) for atherosclerotic patients comparing territories with no proximal vessel wall lesion or stenosis to those with a proximal wall lesions and/or stenosis. *Statistically significant by Wilcoxon rank sum corrected two-sided P < 0.05. #Trend towards significance (P < 0.10). The number of subterritories included in each group is included in the x-axis labels.
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Our data provide evidence that CVR lagtime is prolonged in vascular territories with a proximal vessel wall lesion compared to those without in atherosclerosis and moyamoya patients, although the differences are more marked in the moyamoya group. As the majority of vessel wall lesions in the moyamoya patients resulted in severe stenosis, the greater changes in timing in the moyamoya group may be due to greater degree of luminal stenosis. The mechanism by which greater stenosis contributes to a longer CVR lagtime is not well understood. Possible mechanisms include 1) stenosis of larger feeding vessels resulting in reduction in cerebral perfusion pressure and delayed blood arrival time; 2) less efficient response of moyamoya collateral arteriole smooth muscle compared with healthy vessels; and 3) more rigid vessels or vessels operating near reserve capacity in patients with atherosclerosis. Differences between groups may also reflect different mechanisms of endothelial or smooth muscle dysfunction in atherosclerotic vs. nonatherosclerotic disease, as recent animal work has revealed an important role of the endothelium in vasodilation. 31 Although territories with proximal lesions and/or stenosis appear to react differently based on disease etiology (atherosclerotic vs. nonatherosclerotic), the territories without a proximal vessel wall lesion or stenosis demonstrate similar CVR timing trends.
The maximum CVR is significantly decreased in the presence of a proximal vessel wall lesion in the moyamoya patients only, possibly indicating that it is the CVR lagtime, rather than the commonly assumed overall reactivity, that is impaired in many, although not all, patients with atherosclerotic disease. However, it is also noted that in territories with no visible proximal vessel wall lesion or hemodynamically significant stenosis, the maximum CVR is significantly lower in the atherosclerosis patient group than in the moyamoya patient group. This likely reflects age-related changes in maximum CVR, 32 as the average age in the atherosclerosis group is much higher relative to the moyamoya group (64 years vs. 40 years in the presented patients).
Although analysis of atherosclerosis and moyamoya patients is considered separately, it is noted that the CVR lagtimes in territories without visible proximal vessel disease were not significantly different between the atherosclerosis and moyamoya patients. However, the maximum CVR in territories without proximal vessel disease was greater for the FIGURE 4: Mean 6 standard deviation of the CVR lagtime (A) and maximum CVR (B) for nonatherosclerotic (moyamoya) patients comparing territories with no proximal vessel disease to those with proximal vessel wall lesions and/or stenoses. *Statistically significant by Wilcoxon rank sum corrected two-sided P < 0.05. The number of subterritories included in each group is included in the x-axis labels.
FIGURE 5: Mean 6 standard deviation of CVR lagtime (A) and maximum CVR (B) comparing territories with vs. without a proximal vessel wall lesion or stenosis, separately for all moyamoya patients, moyamoya patients with prior EDAS, and moyamoya patients without prior EDAS. moyamoya group than for the atherosclerosis group. The range and standard deviation of the CVR lagtime and maximum CVR were also greater for the moyamoya group compared to the atherosclerosis group. Such direct comparisons should be interpreted with care, however, as disease chronicity and age cannot be matched between groups due to the differing etiology of these diseases.
Approximately one-half of the moyamoya patients had received prior EDAS. Separate analysis of the moyamoya patients with and without prior EDAS showed that both groups similarly have prolonged CVR lagtime and decreased maximum CVR in territories with proximal vessel disease. The patients with and without prior EDAS were not directly compared due to inherent differences in the groups, including postsurgical physiology as well as differences in disease severity between the groups. Specifically, patients requiring EDAS are inherently more impaired than those not requiring an EDAS, and therefore while the EDAS may improve tissue-level hemodynamics, this improvement may still not lead to an equivalent hemodynamic pattern as an asymptomatic patient never requiring an EDAS. These data imply that patients with prior EDAS have overall prolonged CVR and decreased maximum CVR compared to patients without prior EDAS, but, as described above, interpretation of these data is not straightforward
Higher spatial resolution MRI of the vessel wall has been previously shown to provide morphologic evaluation of the vessel wall and assessment of vessel wall pathology. Vessel wall changes including wall thickening, signal changes, and/or enhancement have been shown to be greater in symptomatic intracranial stenosis compared to asymptomatic patients 33, 34 and to be able to differentiate a variety of disease conditions, including atherosclerosis, moyamoya disease, dissection, and vasculitis. 35, 36 This study adds to the literature by assessing the relationship between intracranial vessel wall plaque or thickening and tissue-level timing and reactivity functioning. Several limitations should also be considered. Several of the atherosclerosis and moyamoya patients had areas of encephalomalacia from prior cortical infarcts involving on average 1-2 of the ASPECTS territories. As shown, the number of territories affected by prior infarct was small and did not affect the overall results. Approximately one-half of the moyamoya patients had received prior EDAS, and it is important to consider these groups separately, as discussed above. It is recognized that moyamoya is generally considered a bilateral disease of variable severity, and in this study only those segments with a discernible proximal vessel wall lesion or hemodynamically significant stenosis are considered diseased. The detection of vessel wall lesions is limited by the sensitivity of the VWI technique, which has been shown to be greater at 7T vs. 3T. 37 However, at this time it
is not feasible to routinely perform 7T MRI clinically.
Different modalities were used for angiography, primarily DSA for the moyamoya group and MRA for the atherosclerosis group. This was due to DSA being the clinical gold standard for moyamoya collateral grading and classification, but MRA and CTA being used more commonly for atherosclerosis. As both of these modalities are able to accurately detect the presence of a stenosis >50%, this difference is not anticipated to be a major confound, given the conservative categorical stenosis classification procedure (see Materials and Methods). The atherosclerosis and nonatherosclerosis groups are not age-matched due to the inherent differences in disease pathology and age of onset, and an age-matched control population was not included in this study. However, the age difference between groups does not impact the primary goal of this work, which was to compare CVR lagtime and maximum between flow territories fed by vessels with measurable wall disease and/or stenosis to flow territories fed by vessels without measurable disease, separately in these patient groups. Finally, the patient group is small, similar to other published work in these populations.
In conclusion, this study provides evidence that vessel wall lesions depicted on VWI without intravenous contrast in patients with intracranial stenosis correlate with functional changes of cerebrovascular reactivity on average in both atherosclerotic and nonatherosclerotic (moyamoya) intracranial stenosis. Two disease entities, atherosclerotic and nonatherosclerotic intracranial stenosis, were studied and shown to have different degrees of change in CVR lagtime and maximum CVR in the presence of a proximal vessel wall lesion. These differences may reflect different mechanisms of endothelial or smooth muscle dysfunction.
